Receptor News and Research

RSS

Stanford-led researchers use microbubbles and ultrasound to detect malignant cancers

A team led by researchers from the Stanford University School of Medicine has demonstrated a way to diagnose cancer without resorting to surgery, raising the possibility of far fewer biopsies.

5 Apr 2017

Scientists identify new gene that drives drug resistance in breast cancer

SCIENTISTS in Salford, UK, have identified a gene which is 'revving the engine of cancer' against the world's most common breast cancer drug.

4 Apr 2017

New drug compound could cut number of hot flushes in menopausal women

Women plagued by frequent hot flushes during the menopause could cut the number of flushes by almost three-quarters, thanks to a new drug compound.

3 Apr 2017

Advanced image analysis technique identifies genetic cell mutations in patients with lung cancer

Researchers have used positron emission tomography to successfully identify genetic cell mutations that can cause lung cancer.

3 Apr 2017

Novel technique helps researchers to study function of neurons that innervate adipose tissue

A research team led by Ana Domingos, from Instituto Gulbenkian de Ciencia, developed a new genetic technique that allows the elimination of specific neurons of the peripheral nervous system without affecting the brain.

3 Apr 2017

Novel highly potent SARDs may offer treatment option for advanced prostate cancer, study reports

Novel molecules called selective androgen receptor degraders (SARDs) may offer the next generation of treatment options for advanced prostate cancer, a new industry-sponsored study reports. The results of this research will be presented Saturday, April 1, at ENDO 2017, the 99th annual meeting of the Endocrine Society, in Orlando, Fla.

2 Apr 2017

BPS shows potential for increasing aggressiveness of breast cancer, study finds

Bisphenol S (BPS), a substitute for the chemical bisphenol A (BPA) in the plastic industry, shows the potential for increasing the aggressiveness of breast cancer through its behavior as an endocrine-disrupting chemical, a new study finds.

2 Apr 2017

Study provides new understanding of molecular mechanisms of HPV-induced tumors

The incidence of human papillomavirus (HPV)-associated (HPV+) head and neck squamous cell carcinoma (HNSCC) of the oropharynx has dramatically increased over the last decade and is now more frequently diagnosed than uterine cervical cancer in the United States.

31 Mar 2017

QIAGEN announces commercialization of AdnaTest kit for clinical research in prostate cancer

QIAGEN N.V. today announced it is commercializing the Research use only AdnaTest Prostate Cancer Panel AR-V7 to detect the androgen receptor splice variant 7 (AR-V7) from liquid biopsies to investigate resistance to potential drugs for advanced prostate cancer.

From QIAGEN Manchester Limited 31 Mar 2017

German scientists design molecular paintbrush technique to control and monitor key intracellular processes

The plasma membrane serves as a major hub for signal cascades to control crucial cellular processes. But it is a fluid medium, which makes the signaling processes difficult to monitor.

31 Mar 2017

Combining anticancer drug with antirheumatic produces improved effects against tumors

Scientists at EPFL and NTU have discovered that combining an anticancer drug with an antirheumatic produces improved effects against tumors. The discovery opens a new path for drug-drug synergy.

30 Mar 2017

Study shows inhibition of transgelin prevents vasculogenic mimicry in breast cancer

An article published in Experimental Biology and Medicine identifies a new signaling pathway involved in breast cancer cell growth. The study, led by Dr. Chan-Wha Kim, from the Department of Biotechnology at Korea University in Seoul, reports that inhibition of the actin-binding protein transgelin prevents vasculogenic mimicry (VM), a process that provides tumor cells with the nutrients required for growth.

29 Mar 2017

Research findings open door to new class of analgesics for treating neuropathic pain

New research published online in The FASEB Journal suggests that a novel therapeutic target called LPCAT2 may prove effective against pain that is not receptive to the current treatments.

29 Mar 2017

World's leading heart failure congress sets new record for abstract submissions

A new record for original science submissions has been set for the world's leading heart failure congress. In addition to the main abstract programme, highly anticipated results from major studies will be presented in the late breaking trial sessions.

29 Mar 2017

Researchers shed light on diverse effects of exercise on individuals

In Japan, due to the changes of lifestyle such as less physical activities than before, more and more people suffer from the lifestyle diseases like metabolic syndromes, type-2 diabetes and hypertension.

28 Mar 2017

Research findings offer potential explanation for opioid-induced itching

Opioids have long been an important tool in the world of pain management, but the side effects of these drugs - from addiction and respiratory failure to severe itching and dizziness, can be overwhelming.

27 Mar 2017

Researchers report discovery of new gene linked to Tau accumulation in AD

Tau pathology is one of the defining features of Alzheimer disease (AD), which is the most common form of dementia in older age.

25 Mar 2017

New gene linked to Tau pathology

Investigators at Rush University Medical Center and the Brigham and Women's Hospital in Boston reported the discovery of a new gene that is associated with susceptibility to a common form of brain pathology called Tau that accumulates in several different conditions, including Alzheimer's disease, certain forms of dementia and Parkinsonian syndromes as well as chronic traumatic encephalopathy that occurs with repeated head injuries.

24 Mar 2017

MSK scientists discover epigenetic mechanism promoting breast cancer

Researchers from Memorial Sloan Kettering Cancer Center (MSK) have identified, for the first time, an epigenetic mechanism promoting breast cancer.

24 Mar 2017

SLU researchers aim to tackle diabetes and obesity by capturing benefits of exercise in pill form

With a series of new grants, Saint Louis University researchers will tackle the twin epidemics of diabetes and obesity by tapping into the potential of two nuclear receptors that control muscle metabolism.

24 Mar 2017

Receptor News and Research

Stanford-led researchers use microbubbles and ultrasound to detect malignant cancers

Scientists identify new gene that drives drug resistance in breast cancer

New drug compound could cut number of hot flushes in menopausal women

Advanced image analysis technique identifies genetic cell mutations in patients with lung cancer

Novel technique helps researchers to study function of neurons that innervate adipose tissue

Novel highly potent SARDs may offer treatment option for advanced prostate cancer, study reports

BPS shows potential for increasing aggressiveness of breast cancer, study finds

Study provides new understanding of molecular mechanisms of HPV-induced tumors

QIAGEN announces commercialization of AdnaTest kit for clinical research in prostate cancer

German scientists design molecular paintbrush technique to control and monitor key intracellular processes

Combining anticancer drug with antirheumatic produces improved effects against tumors

Study shows inhibition of transgelin prevents vasculogenic mimicry in breast cancer

Research findings open door to new class of analgesics for treating neuropathic pain

World's leading heart failure congress sets new record for abstract submissions

Researchers shed light on diverse effects of exercise on individuals

Research findings offer potential explanation for opioid-induced itching

Researchers report discovery of new gene linked to Tau accumulation in AD

New gene linked to Tau pathology

MSK scientists discover epigenetic mechanism promoting breast cancer

SLU researchers aim to tackle diabetes and obesity by capturing benefits of exercise in pill form

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News